These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


307 related items for PubMed ID: 31482487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
    Dengel LT, Norrod AG, Gregory BL, Clancy-Thompson E, Burdick MD, Strieter RM, Slingluff CL, Mullins DW.
    J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
    Satooka H, Ishigaki H, Todo K, Terada K, Agata Y, Itoh Y, Ogasawara K, Hirata T.
    Sci Rep; 2020 May 21; 10(1):8414. PubMed ID: 32439888
    [Abstract] [Full Text] [Related]

  • 6. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
    Trotta T, Costantini S, Colonna G.
    Mol Immunol; 2009 Dec 21; 47(2-3):332-9. PubMed ID: 19800124
    [Abstract] [Full Text] [Related]

  • 7. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M, Carter S, Hofer MJ, Campbell IL.
    Neuropathol Appl Neurobiol; 2010 Aug 21; 36(5):368-87. PubMed ID: 20487305
    [Abstract] [Full Text] [Related]

  • 8. Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.
    Fagète S, Rousseau F, Magistrelli G, Gueneau F, Ravn U, Kosco-Vilbois MH, Fischer N.
    J Biol Chem; 2012 Jan 06; 287(2):1458-67. PubMed ID: 22041899
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
    Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ, Gimotty PA, Facciabene A, Jackson DG, Weber JS, Rodig SJ, Hodi SF, Kandalaft LE, Irving M, Zhang L, Foukas P, Rusakiewicz S, Delorenzi M, Coukos G.
    Cancer Cell; 2019 Jun 10; 35(6):885-900.e10. PubMed ID: 31185212
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
    Torphy RJ, Sun Y, Lin R, Caffrey-Carr A, Fujiwara Y, Ho F, Miller EN, McCarter MD, Lyons TR, Schulick RD, Kedl RM, Zhu Y.
    Nat Commun; 2022 Jan 10; 13(1):97. PubMed ID: 35013216
    [Abstract] [Full Text] [Related]

  • 14. CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.
    Wennerberg E, Kremer V, Childs R, Lundqvist A.
    Cancer Immunol Immunother; 2015 Feb 10; 64(2):225-35. PubMed ID: 25344904
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
    Cox JH, Dean RA, Roberts CR, Overall CM.
    J Biol Chem; 2008 Jul 11; 283(28):19389-99. PubMed ID: 18411283
    [Abstract] [Full Text] [Related]

  • 16. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
    Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW.
    Cancer Immunol Res; 2015 Aug 11; 3(8):956-67. PubMed ID: 26048575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N, Abboud D, Baragli A, Noman MZ, Rogister B, Niclou SP, Heveker N, Janji B, Hanson J, Szpakowska M, Chevigné A.
    Cells; 2019 Jun 18; 8(6):. PubMed ID: 31216755
    [Abstract] [Full Text] [Related]

  • 19. Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line.
    Matsumoto A, Hiroi M, Mori K, Yamamoto N, Ohmori Y.
    Med Sci (Basel); 2023 Apr 25; 11(2):. PubMed ID: 37218983
    [Abstract] [Full Text] [Related]

  • 20. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D, Santos SJ, Baelde HJ, Taminiau AH, Egeler RM, Schilham MW, Hogendoorn PC, Lankester AC.
    J Pathol; 2011 Feb 25; 223(3):347-57. PubMed ID: 21171080
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.